What is Global C-Reactive Protein Test (CRP) Market?
The Global C-Reactive Protein Test (CRP) Market is a comprehensive study of the current trends, growth indicators, and market dynamics that are expected to shape the growth of the Global C-Reactive Protein Test (CRP) Market. The C-Reactive Protein Test (CRP) is a blood test marker for inflammation in the body. It is produced in the liver and its level is measured in the blood. It is used to detect inflammation due to acute conditions or to monitor the severity of chronic diseases. The global market for this test was valued at US$ 660.4 million in 2022. The market is projected to reach a value of US$ 997.8 million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period of 2023-2029.
ELISA, Immunoturbidimetric, CLIA, Others in the Global C-Reactive Protein Test (CRP) Market:
The Global C-Reactive Protein Test (CRP) Market is segmented based on the type of test, which includes ELISA, Immunoturbidimetric, CLIA, and others. The Immunoturbidimetric test is the most common type, accounting for about 60% of the global market. This test is a laboratory technique used in biochemistry to measure the concentration of compounds in solution. It is based on the principle that the concentration of a substance is directly proportional to the amount of light absorbed, or inversely proportional to the amount of light transmitted. The other types of tests, ELISA and CLIA, also have significant market shares, but data for their exact market shares is not available.
Hospitals, Diagnostic Laboratories, Others in the Global C-Reactive Protein Test (CRP) Market:
The Global C-Reactive Protein Test (CRP) Market is also segmented based on its usage in different areas such as hospitals, diagnostic laboratories, and others. Hospitals are the main users of the C-Reactive Protein Test (CRP), accounting for about 75% of the global market. This is because hospitals are the primary healthcare providers where a majority of patients are diagnosed and treated. Diagnostic laboratories also use the C-Reactive Protein Test (CRP) for diagnosing various conditions. However, the exact market share of diagnostic laboratories is not available. Other areas where the C-Reactive Protein Test (CRP) is used include research institutions, academic institutions, and home care settings.
Global C-Reactive Protein Test (CRP) Market Outlook:
The global C-Reactive Protein Test (CRP) market outlook highlights the market's growth and the dominance of key players and sectors. The market was valued at US$ 660.4 million in 2022 and is expected to reach US$ 997.8 million by 2029, growing at a CAGR of 6.0% during the forecast period 2023-2029. The top three players in the market hold about 55% of the global shares, indicating a high level of market concentration. The Immunoturbidimetric test type holds a significant share of about 60% in the market. The primary application of the C-Reactive Protein Test (CRP) is in hospitals, which hold about 75% of the market share.
| Report Metric | Details |
| Report Name | C-Reactive Protein Test (CRP) Market |
| Accounted market size in 2022 | US$ 660.4 million |
| Forecasted market size in 2029 | US$ 997.8 million |
| CAGR | 6.0% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Beckman Coulter, Roche, Siemens Healthineers, Boditech, Wondfo, KANTO CHEMICAL, Kehua Group, Beijing Strong Biotechnologies, Getein Biotech, Randox Laboratories, Spinreact, BioSino, Leadman Biochemistry |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
